On October 18th, the new product launch event hosted by Great Bay Bio (hereinafter referred to as “GBB”) was successfully held in Suzhou, where industry players gathered to celebrate the feast of technological innovation. At the event, GBB announced the official launch of the Intelligent Drug Development Ecosystem. The Intelligent Drug Development Ecosystem empowers the […]

TOYOTA GAZOO Racing World Rally Team further closed the gap in the FIA World Rally Championship with a strong final day performance even as it missed out on overall victory. Takamoto Katsuta was the star of the final day as he completed an excellent return to action, claiming the maximum 12 points on offer by

Ten Hoedt is a former Medtronic President and Executive Committee Member; also a former Chairman of MedTech Europe Commercial and digital health expert Rahma Samow will also join as Director Current Board Chairman Jan Ohrstrom and Director Fred Colen to retire from the Board at year-end after 8 years of service EINDHOVEN, the Netherlands, Oct.

Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare Sanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a significant shareholder With 11,000 talented and passionate people bringing iconic brands to life, Opella poised to ignite new bold development journey Sanofi to become a

VALLOUREC AND ASMO SIGN A STRATEGIC PARTNERSHIP Meudon (France), October 21, 2024 – Vallourec, a world leader in premium seamless tubular solutions, announces the signing of a Memorandum of Understanding (MoU) with Advanced Supply Management Operations (ASMO), a joint venture between DHL and Aramco (through the Saudi Aramco Development Company). ASMO is the first-of-its-kind procurement

The Thailand Board of Investment (BOI) said today that applications for investment promotion in the first nine months of 2024 increased 42% on year in value to a combined 722.5 billion baht (ca. US$ 21.7 billion), the highest level since 2015. Large projects in target sectors such as electrical appliances and electronics (E&E), and digital,

GENEVA, SWITZERLAND / ACCESSWIRE / October 21, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today reported that the European Patent Office (EPO) has issued a Notice of Allowance under Rule 71(3) EPC for Relief’s

ARC Group leverages its experience, expert workforce, and personalized customer relationships to build its brand among industry stakeholders and beyond. Frost & Sullivan recently analyzed the mid-market investment advisory services industry and, based on its findings, recognizes ARC Group with the 2024 Asian Company of the Year Award. The company is one of Asia-Pacific’s leading

Amsterdam and Dubai, 21 October 2024: VEON Ltd. (Nasdaq: VEON; Euronext Amsterdam: VEON), a global digital operator (“VEON” or the “Company”), today announces that, following the filing of the Company’s Form 20-F for the period ended December 31, 2023 (“2023 20-F”) on October 17, 2024, it has received confirmation from the Nasdaq Stock Market (“Nasdaq”)

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announces that the Taiwan Food and Drug Administration (TFDA) has approved NEFECON indicated "to reduce the loss of kidney function in adult patients with primary immunoglobulin A nephropathy (IgAN) who are